This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
A 3-hour one session exposure therapy for public speaking anxiety
Vilnius University
Vilnius, Lithuania
RECRUITINGPublic Speaking Anxiety Scale (PSAS), (Bartholomay & Houlihan, 2016).
Canonical total score will be used. Measure is self-rated, online. The scale consists of 17 self-report statements measured on a Likert-type scale ranging from 1 "not at all", to 5 "extremely". A higher score indicates higher levels of experienced public speaking anxiety.
Time frame: Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment
Liebowitz Social Anxiety Scale - Self-Report (LSAS-SR), (Liebowitz, 2003; Rytwinski et al., 2009)
Canonical total score will be used. Measure is self-rated, online. Items are rated using 4-point Likert scales ranging from 0 to 3. A higher score indicates more severe symptoms.
Time frame: Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment
Brief Fear of Negative Evaluation Scale (BFNE), (Leary, 1983)
Canonical total score will be used. Measure is self-rated, online. The BFNE is a 12-item, 5-point Likert-type scale, ranging from 1 ""not at all" to 5 "extremely". Higher scores indicate higher fear.
Time frame: Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment
Igroup Presence Questionnaire (IPQ)
Canonical total score will be used. Measure is self-rated, online. Each of the 14 items is rated on a 7-point Likert scale and the score is calculated by summing the ratings for each item.
Time frame: Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment
Patient health questionnaire - 9 (PHQ-9), (Spitzer et al., 1999)
Canonical total score will be used. Measure is self-rated, online. PHQ-9 consists of 9 items that are rated depending on how often the symptoms were bothersome using a 4-point scale, ranging from 0 "not at all" to 3 "nearly every day". The ratings are summed for the total score and higher scores indicates more severe depression symtpoms.
Time frame: Pre-treatment, mid-treatment, immediately after the intervention, 3 and 12 months post-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.